Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination
We aimed to highlight the utility of novel dissolving microneedle (MN)-based delivery systems for enhanced transdermal protein delivery. Vaccination remains the most accepted and effective approach in offering protection from infectious diseases. In recent years, much interest has focused on the pos...
Saved in:
Published in | Journal of pharmacy and pharmacology Vol. 67; no. 3; p. 409 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.03.2015
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | We aimed to highlight the utility of novel dissolving microneedle (MN)-based delivery systems for enhanced transdermal protein delivery. Vaccination remains the most accepted and effective approach in offering protection from infectious diseases. In recent years, much interest has focused on the possibility of using minimally invasive MN technologies to replace conventional hypodermic vaccine injections.
The focus of this study was exploitation of dissolving MN array devices fabricated from 20% w/w poly(methyl vinyl ether/maleic acid) using a micromoulding technique, for the facilitated delivery of a model antigen, ovalbumin (OVA).
A series of in-vitro and in-vivo experiments were designed to demonstrate that MN arrays loaded with OVA penetrated the stratum corneum and delivered their payload systemically. The latter was evidenced by the activation of both humoral and cellular inflammatory responses in mice, indicated by the production of immunoglobulins (IgG, IgG1, IgG2a) and inflammatory cytokines, specifically interferon-gamma and interleukin-4. Importantly, the structural integrity of the OVA following incorporation into the MN arrays was maintained.
While enhanced manufacturing strategies are required to improve delivery efficiency and reduce waste, dissolving MN are a promising candidate for 'reduced-risk' vaccination and protein delivery strategies. |
---|---|
AbstractList | We aimed to highlight the utility of novel dissolving microneedle (MN)-based delivery systems for enhanced transdermal protein delivery. Vaccination remains the most accepted and effective approach in offering protection from infectious diseases. In recent years, much interest has focused on the possibility of using minimally invasive MN technologies to replace conventional hypodermic vaccine injections.
The focus of this study was exploitation of dissolving MN array devices fabricated from 20% w/w poly(methyl vinyl ether/maleic acid) using a micromoulding technique, for the facilitated delivery of a model antigen, ovalbumin (OVA).
A series of in-vitro and in-vivo experiments were designed to demonstrate that MN arrays loaded with OVA penetrated the stratum corneum and delivered their payload systemically. The latter was evidenced by the activation of both humoral and cellular inflammatory responses in mice, indicated by the production of immunoglobulins (IgG, IgG1, IgG2a) and inflammatory cytokines, specifically interferon-gamma and interleukin-4. Importantly, the structural integrity of the OVA following incorporation into the MN arrays was maintained.
While enhanced manufacturing strategies are required to improve delivery efficiency and reduce waste, dissolving MN are a promising candidate for 'reduced-risk' vaccination and protein delivery strategies. |
Author | Zaric, Marija Scott, Christopher J Torrisi, Barbara M Al-Zahrani, Sharifah McCrudden, Cian M McCrudden, Maelíosa T C McCarthy, Helen O Donnelly, Ryan F Kissenpfennig, Adrien |
Author_xml | – sequence: 1 givenname: Maelíosa T C surname: McCrudden fullname: McCrudden, Maelíosa T C organization: School of Pharmacy, Medical Biology Centre, Queen's University Belfast, Belfast, UK – sequence: 2 givenname: Barbara M surname: Torrisi fullname: Torrisi, Barbara M – sequence: 3 givenname: Sharifah surname: Al-Zahrani fullname: Al-Zahrani, Sharifah – sequence: 4 givenname: Cian M surname: McCrudden fullname: McCrudden, Cian M – sequence: 5 givenname: Marija surname: Zaric fullname: Zaric, Marija – sequence: 6 givenname: Christopher J surname: Scott fullname: Scott, Christopher J – sequence: 7 givenname: Adrien surname: Kissenpfennig fullname: Kissenpfennig, Adrien – sequence: 8 givenname: Helen O surname: McCarthy fullname: McCarthy, Helen O – sequence: 9 givenname: Ryan F surname: Donnelly fullname: Donnelly, Ryan F |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24673568$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tKw0AYhQdR7EU3PoDMC6TOPRN3UqwKBTe6Ln9m_rRTkkmYiYW-vcHL2Rw4H3xwFuQy9hEJueNsxac8HIfDsOJCKHtB5oIpUZRc2xlZ5HxkjJXGmGsyE8qUUhs7J3kLGVOBcR8iYkJPfci5b08h7mkXXJr06FukkBKcM236RIfUjxgi9diGE6bzIx2mIY4B2h-O8QDRTaoQxwQeUzeBEzgXIoyhjzfkqoE24-1fL8nn5vlj_Vps31_e1k_bwhkhbKErKBvXSKyNtaoUTIKECidkjZPeCq54KSsuHGNOKSN1pcDUtRIlaK1RLMn9r3f4qjv0uyGFDtJ59_9efAPGKl2A |
CitedBy_id | crossref_primary_10_1088_1361_6528_ace97b crossref_primary_10_1128_AAC_02612_18 crossref_primary_10_1016_j_nano_2016_11_019 crossref_primary_10_1080_17425247_2018_1505860 crossref_primary_10_1007_s11095_017_2223_2 crossref_primary_10_1007_s13346_015_0252_0 crossref_primary_10_1016_j_jconrel_2019_11_023 crossref_primary_10_3390_pharmaceutics12060569 crossref_primary_10_1007_s13346_022_01190_x crossref_primary_10_1007_s13770_023_00527_y crossref_primary_10_1080_17425247_2021_1823964 crossref_primary_10_1016_j_addr_2021_06_002 crossref_primary_10_1016_j_apsb_2021_03_003 crossref_primary_10_1021_acs_molpharmaceut_8b00895 crossref_primary_10_3389_fvets_2022_891286 crossref_primary_10_1517_17425247_2016_1115835 crossref_primary_10_1016_j_ijpharm_2018_07_049 crossref_primary_10_1016_j_jconrel_2017_07_032 crossref_primary_10_3390_catal7010004 crossref_primary_10_1116_1_4960715 crossref_primary_10_1038_s41598_018_30290_3 crossref_primary_10_1016_j_ijpharm_2019_05_066 crossref_primary_10_1021_acsbiomaterials_9b00961 crossref_primary_10_1016_j_biomaterials_2020_120410 crossref_primary_10_1016_j_isci_2022_105045 crossref_primary_10_1080_17425247_2018_1522301 crossref_primary_10_3390_vaccines7040159 |
ContentType | Journal Article |
Copyright | 2014 Royal Pharmaceutical Society. |
Copyright_xml | – notice: 2014 Royal Pharmaceutical Society. |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1111/jphp.12248 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2042-7158 |
ExternalDocumentID | 24673568 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Biotechnology and Biological Sciences Research Council grantid: BB/K020234/1 – fundername: Wellcome Trust grantid: WT094085MA – fundername: Wellcome Trust – fundername: Biotechnology and Biological Sciences Research Council grantid: BB/E020534/1 – fundername: Biotechnology and Biological Sciences Research Council grantid: BB/FOF/287 |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1CY 1OB 1OC 29L 31~ 33P 3O- 3SF 3WU 4.4 50Y 50Z 52M 52O 52S 52T 52U 52V 52W 53G 5GY 5RE 5WD 702 7PT 8-0 8-1 8-3 8-4 8-5 8WZ 930 A01 A03 A6W AABZA AACZT AAESR AAEVG AAHHS AAONW AAPGJ AAPXW AARHZ AAUAY AAVAP AAWDT AAYOK AAZKR ABCUV ABJNI ABLJU ABNHQ ABOCM ABPQP ABPTD ABPVW ABQNK ABWST ABXVV ACBWZ ACCFJ ACFBH ACFRR ACGFO ACGFS ACIWK ACMXC ACPOU ACPRK ACUTJ ACXQS ACYHN ACZBC ADBBV ADEOM ADIPN ADIZJ ADKYN ADMGS ADQBN ADVEK ADXAS ADZMN AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFFNX AFFZL AFGKR AFPWT AFRAH AFXAL AFYAG AFZJQ AGMDO AGQXC AGUTN AHMBA AI. AIAGR AIURR AIWBW AJAOE AJBDE AJEEA ALAGY ALMA_UNASSIGNED_HOLDINGS AMBMR AMYDB APJGH AQDSO ASPBG ATGXG ATUGU AVNTJ AVWKF AZBYB AZFZN AZVAB BAFTC BCRHZ BDRZF BEYMZ BHBCM BROTX BRXPI C45 CAG CGR COF CS3 CUY CVF D-6 D-7 D-E D-F DCZOG DPXWK DRFUL DRMAN DRSTM DU5 EBS ECM EIF EJD EMOBN F00 F01 F04 F5P FECEO FEDTE FLUFQ FOEOM G-S G.N GODZA H.X H13 HF~ HVGLF HZ~ KBUDW KOP KSI KSN L7B LATKE LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N04 N05 NF~ NNB NOMLY NPM O66 O9- OAUYM OCZFY OJZSN OPAEJ OVD OWPYF P2P P2W P2X P2Z P4D PALCI PQQKQ Q.N QB0 R.K RIWAO RJQFR ROL ROX RX1 SUPJJ TEORI TMA UB1 V8K VH1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WVDHM X7M XG1 YCJ ZGI ZXP ZZTAW ~IA ~WT |
ID | FETCH-LOGICAL-c6228-59a7fcf3eb68847203a3a9e22886c3d8214173912c00c4463594a6bb427a555e2 |
IngestDate | Wed Oct 16 00:44:48 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | microneedles laser-engineering protein delivery vaccination |
Language | English |
License | 2014 Royal Pharmaceutical Society. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c6228-59a7fcf3eb68847203a3a9e22886c3d8214173912c00c4463594a6bb427a555e2 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938851 |
PMID | 24673568 |
ParticipantIDs | pubmed_primary_24673568 |
PublicationCentury | 2000 |
PublicationDate | March 2015 |
PublicationDateYYYYMMDD | 2015-03-01 |
PublicationDate_xml | – month: 03 year: 2015 text: March 2015 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of pharmacy and pharmacology |
PublicationTitleAlternate | J Pharm Pharmacol |
PublicationYear | 2015 |
SSID | ssj0007666 |
Score | 2.3127935 |
Snippet | We aimed to highlight the utility of novel dissolving microneedle (MN)-based delivery systems for enhanced transdermal protein delivery. Vaccination remains... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 409 |
SubjectTerms | Administration, Cutaneous Animals Antigens - administration & dosage Drug Delivery Systems Interferon-gamma - blood Interleukin-4 - blood Lasers Maleates - chemistry Methyl Ethers - chemistry Mice Microinjections Needles Ovalbumin - administration & dosage Polyvinyls - chemistry Skin - metabolism Skin Absorption Solubility Vaccination - methods Vaccines - administration & dosage |
Title | Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24673568 |
Volume | 67 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBWb9NJL6fdHmqJDycXxYsuWbPUWti2hdEMOGwi9BFmWWIPjGO-mkPy1_LmOJHutbhtIezFG4zVG7-1oNBo9IfSRwZBQciVCpuHvlvJChLxkDKYqMtIFp2Vij-mcn7Djs_TbOT2fTO68qqXrdTGVt3_dV_I_qEIb4Gp2yf4DspuXQgPcA75wBYTh-iCMv8MQ1IWqlxSE0NGsrl_VNkdwaSrtoLmsVSC6TtxY4YXA6jLYCtjaVGRYvacWmpp15bYyBqpZuqqAyuR9S-O56-CnkLJqRhT_DGdbp4Ht5JzaURB7rDKWs-56cHNzoWq7Rv_5aiWCReBluztwO5W3FDLma4_q8IdYdu4UKis1Xekxnf3b-2fGb839lEZMx5quqbKuj5hNQ1nsRN0HP-2O7ej5mHhON7UCC_cOBu2ynZr1w9x_CHq3vbS0IDBUJJQ9wLolzD2YdtBOlptTQ05MoqgPAjKYFvZquLZwbPMRRn26_-HWTMZGNIun6EmPHT5yvHqGJqp5jg5OexwP8WLcmrc6xAf41AP1BVptkw-P5MMe-bAjHwZq4Z58eCDfJ7yhnrUP1MMe9bBHvZfo7OuXxew47E_wCCUjJA8pF5mWOlEFyyEMIlEiEsEVmHImkzIncRpnCY-JjCKZphD88lSwokhJJiilirxCuw187huEtdC8VIoWXMCDmuZFwnIVSa1jDbf0LXrtOvOidTItF0M3v7vXsocej_R7jx5p8AtqH4LMdfHBwvkLHUyEag |
link.rule.ids | 780 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Laser-engineered+dissolving+microneedle+arrays+for+protein+delivery%3A+potential+for+enhanced+intradermal+vaccination&rft.jtitle=Journal+of+pharmacy+and+pharmacology&rft.au=McCrudden%2C+Mael%C3%ADosa+T+C&rft.au=Torrisi%2C+Barbara+M&rft.au=Al-Zahrani%2C+Sharifah&rft.au=McCrudden%2C+Cian+M&rft.date=2015-03-01&rft.eissn=2042-7158&rft.volume=67&rft.issue=3&rft.spage=409&rft_id=info:doi/10.1111%2Fjphp.12248&rft_id=info%3Apmid%2F24673568&rft_id=info%3Apmid%2F24673568&rft.externalDocID=24673568 |